Small Molecule DNA and RNA Binders 2002
DOI: 10.1002/3527601783.ch16
|View full text |Cite
|
Sign up to set email alerts
|

Dicationic DNA Minor Groove Binders as Antimicrobial Agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
159
0
1

Year Published

2006
2006
2023
2023

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 80 publications
(166 citation statements)
references
References 123 publications
(254 reference statements)
1
159
0
1
Order By: Relevance
“…Diamidines have excellent transport properties into a variety of cells [3][4][5][6] and an orally available prodrug of the diamidine, DB75, furamidine (Figure 1), is currently in phase III clinical trials against trypanosomes, which cause sleeping sickness, as well as other microbial parasites. 4,[7][8][9][10][11] DB75 binds strongly in the minor groove of DNA and recognizes sequences of at least four AT base pairs. [7][8][9] For design of new agents that target additional disease organisms/cells as well as evading any possible resistance that could develop, we have focused on modifications of the structure, heterocycles, and properties of the basic units of the DB75 molecule.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Diamidines have excellent transport properties into a variety of cells [3][4][5][6] and an orally available prodrug of the diamidine, DB75, furamidine (Figure 1), is currently in phase III clinical trials against trypanosomes, which cause sleeping sickness, as well as other microbial parasites. 4,[7][8][9][10][11] DB75 binds strongly in the minor groove of DNA and recognizes sequences of at least four AT base pairs. [7][8][9] For design of new agents that target additional disease organisms/cells as well as evading any possible resistance that could develop, we have focused on modifications of the structure, heterocycles, and properties of the basic units of the DB75 molecule.…”
Section: Introductionmentioning
confidence: 99%
“…4,[7][8][9][10][11] DB75 binds strongly in the minor groove of DNA and recognizes sequences of at least four AT base pairs. [7][8][9] For design of new agents that target additional disease organisms/cells as well as evading any possible resistance that could develop, we have focused on modifications of the structure, heterocycles, and properties of the basic units of the DB75 molecule. A key aim of the design considerations was to discover motifs that could expand the sequence recognition properties of diamidines by including a variety of nitrogen heterocycles into molecules of different shape.…”
Section: Introductionmentioning
confidence: 99%
“…As described above, the diamidines are attractive for development due to their demonstrated low toxicity in humans, extensive clinical testing and cell uptake properties. 1,2,14,15 In order to accomplish the drug development and molecular recognition goals, a variety of dications, such as those shown in Figure 1, are being designed and prepared. The synthetic compounds are screened by footprinting and Tm methods to select for structures that can selectively target DNA with high affinity.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4] Furamidine (2) is the parent compound of this class, and it's methoxime prodrug (3) (Pafuramidine) is currently in clinical trials for treatment of African Sleeping sickness, malaria, and pneumocystis carinii pneumonia. [4][5] Satisfactory methods for conversion of the intermediate bis-nitrile 1 to 2 and 3 are available. 1,6 Several methods for the synthesis of bis-nitrile 1 are also available; 6-8 however many of these methods require multiple steps and/or are not high yielding.…”
Section: Introductionmentioning
confidence: 99%